Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q1 2025 (March 31)4holders −1
0new positions
1sold out
1famous investor
$0.19avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($39K), Clear Street LLC ($10K) and UBS Group AG ($9K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $733 |
All 13F filers, Q4 2024 → Q1 2025: 47,618 shares bought and 16,716 shares sold, net +30,902 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Armistice Capital, LLC | — | No change | 204,082 | $39K |
| Clear Street LLC | — | Reduce -0.0% | 55,122 | $10K |
| UBS Group AG | — | Add +7160.6% | 48,283 | $9K |
| Citadel Advisors | — | Reduce -28.4% | 35,988 | $7K |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.